Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03932409 |
Title | Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer (FIERCE) |
Acronym | FIERCE |
Recruitment | Recruiting |
Gender | female |
Phase | Phase I |
Variant Requirements | No |
Sponsors | University of Oklahoma |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |